KAPA · Kairos Pharma, LTD.
$0.24
0.00 (-1.62%)
At close · Aug 28
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has experienced recurring losses from operations since inception and incurred a net loss of $3,042 and used cash in operations of $2,048 during the six months ended June 30, 2026. These factors raise substantial doubt about the Company's ability to continue as a going concern. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$5.62M
Shares
23.70M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-20 | 471,906 | 22,409,767 | 22,881,673 | 66.4% |
| 2026-07-13 | 5,929,855 | 48,077,648 | 54,007,503 | 63.5% |
| 2026-07-06 | 11,434 | 209,192 | 220,626 | 66.6% |
| 2026-06-29 | 21,284 | 209,615 | 230,899 | 66.6% |
| 2026-06-22 | 25,327 | 438,906 | 464,233 | 46.2% |
| 2026-06-15 | 9,979 | 180,384 | 190,363 | 64.8% |
| 2026-06-08 | 12,834 | 359,821 | 372,655 | 65.7% |
| 2026-06-01 | 29,538 | 406,903 | 436,441 | 65.0% |
| 2026-05-25 | 11,660 | 241,393 | 253,053 | 73.3% |
| 2026-05-18 | 135,893 | 851,408 | 987,301 | 70.6% |
| 2026-05-11 | 47,666 | 915,897 | 963,563 | 65.8% |
| 2026-05-04 | 6,461 | 259,934 | 266,395 | 68.7% |
| 2026-04-27 | 5,592 | 240,653 | 246,245 | 49.5% |
| 2026-04-20 | 31,711 | 455,282 | 486,993 | 61.9% |
| 2026-04-13 | 14,616 | 200,493 | 215,109 | 60.8% |
| 2026-04-06 | 19,618 | 181,411 | 201,029 | 70.6% |
| 2026-03-30 | 14,424 | 176,471 | 190,895 | 64.3% |
| 2026-03-23 | 6,529 | 225,908 | 232,437 | 54.0% |
| 2026-03-16 | 40,788 | 274,463 | 315,251 | 44.4% |
| 2026-03-09 | 61,158 | 358,519 | 419,677 | 61.8% |
| 2026-03-02 | 254,019 | 727,395 | 981,414 | 59.7% |
| 2026-02-23 | 566,671 | 11,205,876 | 11,772,547 | 49.5% |
| 2026-02-16 | 7,101 | 249,418 | 256,519 | 65.4% |
| 2026-02-09 | 9,884 | 187,921 | 197,805 | 52.4% |
| 2026-02-02 | 13,446 | 269,579 | 283,025 | 53.2% |
| 2026-01-26 | 25,884 | 499,516 | 525,400 | 53.5% |
| 2026-01-19 | 14,048 | 356,271 | 370,319 | 47.0% |
| 2026-01-12 | 17,063 | 315,121 | 332,184 | 64.7% |
| 2026-01-05 | 31,827 | 952,613 | 984,440 | 70.6% |
| 2025-12-29 | 11,561 | 322,603 | 334,164 | 68.1% |
| 2025-12-22 | 25,329 | 568,152 | 593,481 | 67.1% |
| 2025-12-15 | 20,076 | 410,717 | 430,793 | 64.4% |
| 2025-12-08 | 12,900 | 385,120 | 398,020 | 61.7% |
| 2025-12-01 | 9,328 | 439,148 | 448,476 | 59.2% |
| 2025-11-24 | 16,387 | 181,306 | 197,693 | 48.6% |
| 2025-11-17 | 21,387 | 485,239 | 506,626 | 62.7% |
| 2025-11-10 | 18,232 | 545,998 | 564,230 | 57.5% |
| 2025-11-03 | 11,151 | 1,086,175 | 1,097,326 | 58.5% |
| 2025-10-27 | 13,773 | 587,368 | 601,141 | 69.4% |
| 2025-10-20 | 29,005 | 1,070,992 | 1,099,997 | 65.4% |
| 2025-10-13 | 33,495 | 1,021,241 | 1,054,736 | 66.6% |
| 2025-10-06 | 126,160 | 2,126,861 | 2,253,021 | 60.2% |
| 2025-09-29 | 54,261 | 1,438,409 | 1,492,670 | 65.2% |
| 2025-09-22 | 56,457 | 2,049,237 | 2,105,694 | 52.1% |
| 2025-09-15 | 131,750 | 6,404,183 | 6,535,933 | 58.0% |
| 2025-09-08 | 189,568 | 5,027,666 | 5,217,234 | 55.6% |
| 2025-09-01 | 165,543 | 6,039,144 | 6,204,687 | 39.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1962011
CUSIP
48301N104
13F (30d)
14 filings
14 filers
Visit website
Investor relations